HRS-7450

· Fujian Shengdi Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-7450, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke. [Phase 2]